Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 3 1

Status

Unknown 135Not yet recruiting 51Recruiting 42Completed 36Active not recruiting 8Withdrawn 3Terminated 3Enrolling by invitation 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 2Gynecologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 2Uterine Cervical Neoplasms 1Ovarian Neoplasms 1Endometrial Neoplasms 1

Interventions

Cyclophosphamide 389Carboplatin 343Gemcitabine 331pembrolizumab 328Cisplatin 327Paclitaxel 294Radiotherapy 291Docetaxel 285Bevacizumab 249Rituximab 233Capecitabine 221Nivolumab 218Dexamethasone 205Fluorouracil 189fludarabine 177Oxaliplatin 177Pemetrexed 153Doxorubicin 152Irinotecan 147Etoposide 144Leucovorin 143Cytarabine 133Bortezomib 129fludarabine phosphate 128Cetuximab 126Lenalidomide 125Filgrastim 119Erlotinib Hydrochloride 119Temozolomide 111Radiosurgery 110

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Interventional × anlotinib × Clear all
NCT06507891 2024-07-18

A Clinical Study to Evaluate the Tolerance, Pharmacokinetics and Efficacy of TQ-A3334 Tablets

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Phase 1/2 Terminated
30 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03866980 2024-04-03

A Study of Anti-PD-1 AK105 in Patients With Metastatic Nonsquamous Non-small Cell Lung Cancer

Akeso

Phase 3 Terminated
164 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02558348 2019-06-19

AL3818

Advenchen Laboratories, LLC

Phase 1/2 Terminated
12 enrolled
Gynecologic

Uterine Cervical Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡